CIBC Asset Management Inc Buys 993 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CIBC Asset Management Inc increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 30,420 shares of the company’s stock after acquiring an additional 993 shares during the period. CIBC Asset Management Inc’s holdings in HCA Healthcare were worth $9,131,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management raised its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after buying an additional 125 shares during the period. Canoe Financial LP bought a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Capital Performance Advisors LLP bought a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC bought a new stake in HCA Healthcare in the third quarter valued at approximately $44,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of several research analyst reports. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Barclays decreased their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Finally, Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Trading Up 0.2 %

Shares of HCA stock opened at $316.95 on Wednesday. The stock’s fifty day moving average price is $313.18 and its two-hundred day moving average price is $351.78. The company has a market cap of $80.28 billion, a PE ratio of 14.43, a P/E/G ratio of 1.11 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business posted $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 12.02%.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.